The decision to wait for more evidence means it’s very unlikely a Covid-19 vaccine will see any form of approval before Election Day.
A key FDA vaccine committee declined to vote on a Covid-19 vaccine
More Stories
Record Korean Cases; Trader’s Guide to Rollout: Virus Update
California Hits Record; Trader’s Guide to Rollout: Virus Update
AstraZeneca to Buy Alexion for $39 Billion in Rare-Disease Push